semaglutide patent expiry in india Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India

semaglutide weight-loss drug patent has expired in India, Indian pharmaceutical has wasted no-time to announce generics. What is the most pressing concern about semaglutide generics in India? ✅️Use without prescription is risky

20.74

★★★★☆4.8 (126)

India Obesity Crisis: The Expiry of Ozempic's Patent in 2026 Could Revolutionize India's Battle Against Obesity, ETPharma

24.16

★★★★★4.9 (98)

Ozempic just got cheaper in India. But this isn't just about one drug. After Novo Nordisk's patent expiry, multiple Indian pharma companies have launched lower-cost versions of semaglutide- the molecule used for

22.13

★★★★★5.0 (157)

50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026

22.69

★★★★★4.7 (84)

Indian pharma launches low-cost Ozempic generics as patent expires

20.06

★★★★★4.9 (203)

India is set for a surge in cheaper weight-loss drugs as the patent for semaglutide, used in Ozempic and Wegovy, expires, with generics expected to cut prices by over 50% and expand

29.65

★★★★★5.0 (176)

With semaglutide patents expiring in India, domestic drugmakers like Dr. Reddy's, Glenmark, Natco, and Alkem are launching affordable versions of Ozempic and Wegovy. Prices have dropped from Rs 11,000 to as low

28.80

★★★★★4.8 (132)